S. M. Bakanay Et Al. , "Minimal Residual Plasma Cell Content of Autulogous Grafts, Chemosensitivity to Induction or High Dose Therapy and Pre/Post Transplant PET Negativity Predict Long Term Disease Free Survival in Multiple Myeloma.," 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , vol.120, Georgia, United States Of America, 2012
Bakanay, S. M. Et Al. 2012. Minimal Residual Plasma Cell Content of Autulogous Grafts, Chemosensitivity to Induction or High Dose Therapy and Pre/Post Transplant PET Negativity Predict Long Term Disease Free Survival in Multiple Myeloma.. 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , (Georgia, United States Of America).
Bakanay, S. M., Dalva, K., Koksoy, B. E., Ayyildiz, E., ÖZCAN, M., İLHAN, O., ... BEKSAÇ, M.(2012). Minimal Residual Plasma Cell Content of Autulogous Grafts, Chemosensitivity to Induction or High Dose Therapy and Pre/Post Transplant PET Negativity Predict Long Term Disease Free Survival in Multiple Myeloma. . 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Georgia, United States Of America
Bakanay, Sule Et Al. "Minimal Residual Plasma Cell Content of Autulogous Grafts, Chemosensitivity to Induction or High Dose Therapy and Pre/Post Transplant PET Negativity Predict Long Term Disease Free Survival in Multiple Myeloma.," 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Georgia, United States Of America, 2012
Bakanay, Sule M. Et Al. "Minimal Residual Plasma Cell Content of Autulogous Grafts, Chemosensitivity to Induction or High Dose Therapy and Pre/Post Transplant PET Negativity Predict Long Term Disease Free Survival in Multiple Myeloma.." 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , Georgia, United States Of America, 2012
Bakanay, S. M. Et Al. (2012) . "Minimal Residual Plasma Cell Content of Autulogous Grafts, Chemosensitivity to Induction or High Dose Therapy and Pre/Post Transplant PET Negativity Predict Long Term Disease Free Survival in Multiple Myeloma.." 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , Georgia, United States Of America.
@conferencepaper{conferencepaper, author={Sule Mine Bakanay Et Al. }, title={Minimal Residual Plasma Cell Content of Autulogous Grafts, Chemosensitivity to Induction or High Dose Therapy and Pre/Post Transplant PET Negativity Predict Long Term Disease Free Survival in Multiple Myeloma.}, congress name={54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)}, city={Georgia}, country={United States Of America}, year={2012}}